T-cell subsets in lymph nodes identify a subgroup of follicular lymphoma patients with favorable outcome

References

• Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Ann Oncol. 1998;9:717–720.
   PubMed Web of Science ®Google Scholar
• Pulte D, Jansen L, Gondos A, et al. Survival of patients with non-Hodgkin lymphoma in Germany in the early 21st century. Leuk Lymphoma. 2013;54:979–985.
   PubMed Web of Science ®Google Scholar
• Horning SJ. Natural history of and therapy for the indolent non-Hodgkin’s lymphomas. Semin Oncol. 1993;20:75–88.
   PubMed Web of Science ®Google Scholar
• Mourcin F, Pangault C, Amin-Ali R, et al. Stromal cell contribution to human follicular lymphoma pathogenesis. Front Immunol. 2012;3:1–7.
   PubMed Web of Science ®Google Scholar
• Rimsza LM, Jaramillo MC. Indolent lymphoma: follicular lymphoma and the microenvironment – insights from gene expression profiling. Hematol Am Soc Hematol Educ Progr. 2014;1:163–168.
   Google Scholar
• Dave SS, Wright G, Tan B, et al. Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med. 2004;351:2159–2169.
   PubMed Web of Science ®Google Scholar
• Glas AM, Kersten MJ, Delahaye LJMJ, et al. Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood. 2005;105:301–307.
   PubMed Web of Science ®Google Scholar
• Janikova A, Tichy B, Supikova J, et al. Gene expression profiling in follicular lymphoma and its implication for clinical practice. Leuk Lymphoma. 2011;52:59–68.
   PubMed Web of Science ®Google Scholar
• Bohen SP, Troyanskaya OG, Alter O, et al. Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci USA. 2003;100:1926–1930.
   PubMed Web of Science ®Google Scholar
• Wahlin BE, Sander B, Christensson B, et al. Entourage: the immune microenvironment following follicular lymphoma. Blood Cancer J. 2012;2:e52.
   PubMed Web of Science ®Google Scholar
• Wahlin BE, Aggarwal M, Montes-Moreno S, et al. A unifying microenvironment model in follicular lymphoma: outcome is predicted by programed death-1-positive, regulatory, cytotoxic, and helper T cells and macrophages. Clin Cancer Res. 2010;16:637–650.
   PubMed Web of Science ®Google Scholar
• Wahlin BE, Sander B, Christensson B, et al. CD8+ T-cell content in diagnostic lymph nodes measured by flow cytometry is a predictor of survival in follicular lymphoma. Clin Cancer Res. 2007;13:388–397.
   PubMed Web of Science ®Google Scholar
• Sander B, de Jong D, Rosenwald A, et al. The reliability of immunohistochemical analysis of the tumor microenvironment in follicular lymphoma: a validation study from the Lunenburg Lymphoma Biomarker Consortium. Haematologica. 2014;99:715–725.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of hematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research Cancer (IARC); 2008.
   Google Scholar
• Carreras J. High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood. 2006;108:2957–2964.
   PubMed Web of Science ®Google Scholar
• Wahlin BE, Sundström C, Holte H, et al. T cells in tumors and blood predict outcome in follicular lymphoma treated with rituximab. Clin Cancer Res. 2011;17:4136–4144.
   PubMed Web of Science ®Google Scholar
• Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–586.
   PubMed Web of Science ®Google Scholar
• Martínez A, Aymerich M, Castillo M, et al. Routine use of immunophenotype by flow cytometry in tissues with suspected hematological malignancies. Cytometry B Clin Cytom. 2003;56:8–15.
   PubMed Web of Science ®Google Scholar
• Carreras J, Lopez-Guillermo A, Roncador G, et al. High numbers of tumor-infiltrating programed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol. 2009;27:1470–1476.
   PubMed Web of Science ®Google Scholar
• Solal-Céligny P, Roy P, Colombat P, et al. Follicular Lymphoma International Prognostic Index. Blood. 2004;104:1258–1265.
   PubMed Web of Science ®Google Scholar
• Álvaro-Naranjo T, Lejeune M, Salvadó MT, et al. Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients. J Clin Oncol. 2006;24:5350–5357.
   PubMed Web of Science ®Google Scholar
• Farinha P, Al-Tourah A, Gill K, et al. The architectural pattern of FOXP3-positive T cells in follicular lymphoma is an independent predictor of survival and histologic transformation. Blood. 2010;115:289–295.
   PubMed Web of Science ®Google Scholar
• Farinha P, Masoudi H, Skinnider BF, et al. Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood. 2005;106:2169–2174.
   PubMed Web of Science ®Google Scholar
• Glas AM, Knoops L, Delahaye L, et al. Gene-expression and immunohistochemical study of specific T-cell subsets and accessory cell types in the transformation and prognosis of follicular lymphoma. J Clin Oncol. 2007;25:390–398.
   PubMed Web of Science ®Google Scholar
• Lee AM, Clear AJ, Calaminici M, et al. Number of CD4+ cells and location of forkhead box protein P3-positive cells in diagnostic follicular lymphoma tissue microarrays correlates with outcome. J Clin Oncol. 2006;24:5052–5059.
   PubMed Web of Science ®Google Scholar
• Kiaii S, Clear AJ, Ramsay AG, et al. Follicular lymphoma cells induce changes in T-cell gene expression and function: potential impact on survival and risk of transformation. J Clin Oncol. 2013;31:2654–2661.
   PubMed Web of Science ®Google Scholar
• Chang K-C, Huang X, Medeiros LJ, et al. Germinal center-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. J Pathol. 2003;201:404–412.
   PubMed Web of Science ®Google Scholar
• Shiozawa E, Yamochi-Onizuka T, Yamochi T, et al. Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein. Pathol Res Pract. 2003;199:293–302.
   PubMed Web of Science ®Google Scholar
• Relander T, Johnson NA, Farinha P, et al. Prognostic factors in follicular lymphoma. J Clin Oncol. 2010;28:2902–2913.
   PubMed Web of Science ®Google Scholar
• Laurent C, Müller S, Do C, et al. Distribution, function, and prognostic value of cytotoxic T lymphocytes in follicular lymphoma: a 3-D tissue-imaging study. Blood. 2013;118:5371–5379.
   Web of Science ®Google Scholar
• de Jong D, Koster A, Hagenbeek A, et al. Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols. Haematologica. 2009;94:70–77.
   PubMed Web of Science ®Google Scholar
• Churlaud G, Pitoiset F, Jebbawi F, et al. Human and mouse CD8(+)CD25(+)FOXP3(+) regulatory T cells at steady state and during interleukin-2 therapy. Front Immunol. 2015;6:171.
   PubMed Web of Science ®Google Scholar
• Mayer CT, Floess S, Baru AM, et al. CD8+ Foxp3+ T cells share developmental and phenotypic features with classical CD4+ Foxp3+ regulatory T cells but lack potent suppressive activity. Eur J Immunol. 2011;41:716–725.
   PubMed Web of Science ®Google Scholar
• Duraiswamy J, Ibegbu CC, Masopust D, et al. Phenotype, function, and gene expression profiles of programed death-1(hi) CD8 T cells in healthy human adults. J Immunol. 2011;186:4200–4212.
   PubMed Web of Science ®Google Scholar
• Focosi D, Bestagno M, Burrone O, et al. CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol. 2009;87:107–116.
   PubMed Web of Science ®Google Scholar
• Marinova E, Han S, Zheng B. Germinal center helper T cells are dual functional regulatory cells with suppressive activity to conventional CD4+ T cells. J Immunol. 2007;178:5010–5017.
   PubMed Web of Science ®Google Scholar
• Kim JR, Lim HW, Kang SG, et al. Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination. BMC Immunol. 2005;6:3.
   PubMed Web of Science ®Google Scholar
• Wallin EF, Jolly EC, Bradley JA, et al. Human T-follicular helper and T-follicular regulatory cell maintenance is independent of germinal centers. Blood. 2014;124:2666–2674.
   PubMed Web of Science ®Google Scholar
• Yang Z-Z, Grote DM, Ziesmer SC, et al. PD-1 expression defines two distinct T-cell sub-populations in follicular lymphoma that differentially impact patient survival. Blood Cancer J. 2015;5:e281.
   PubMed Web of Science ®Google Scholar